← Open Payments lookup

AMANDA FINLAYSON: Open Payments

NPI 1740773829 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,314 in 85 payments from 32 companies in 2025. Trend: 2023 $2,402 · 2024 $1,739 · 2025 $2,314

Food & beverage: $1,974Education: $340
CompanyPaymentsAmount
Janssen Biotech, Inc.18$479
GlaxoSmithKline, LLC.9$216
AstraZeneca Pharmaceuticals LP5$197
Merck Sharp & Dohme LLC5$129
Daiichi Sankyo Inc.2$120
Novartis Pharmaceuticals Corporation4$107
SEAGEN INC.1$95
Bayer Healthcare Pharmaceuticals Inc.4$83
PharmaEssentia USA Corporation3$77
Ipsen Biopharmaceuticals, Inc1$61

Products named: ERLEADA, DARZALEX, LYNPARZA, Enhertu, JEMPERLI, KEYTRUDA, OJJAARA, CARVYKTI.

Industry payments across AZ — which companies pay providers there.